IMP A SDB — Implantica AG Income Statement
0.000.00%
Last trade - 00:00
- SEK35.32bn
- SEK34.39bn
- €1.41m
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.028 | 0.152 | 0.387 | 0.842 | 1.41 |
Cost of Revenue | |||||
Gross Profit | -1.2 | -1.08 | -0.867 | -0.421 | 0.091 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.6 | 10.8 | 13.5 | 19.3 | 23.2 |
Operating Profit | -4.57 | -10.6 | -13.1 | -18.4 | -21.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.96 | -10.3 | -15.4 | -21.4 | -24.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.8 | -10.3 | -15.5 | -21.4 | -24.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -4.8 | -10.3 | -15.4 | -20.8 | -23.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.8 | -10.3 | -15.4 | -20.8 | -23.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.053 | -0.082 | -0.013 | -0.018 | -0.02 |
Dividends per Share |